OnePin Peptide Library · Bioregulators
Bronchogen
Bronchogen (Khavinson)
Bronchogen is a synthetic tripeptide bioregulator (Ala-Glu-Asp) developed by Professor Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology. It belongs to the Khavinson peptide bioregulator class, which are short peptides designed to target specific tissues. Bronchogen is designed to act on bronchial and lung tissue, supporting respiratory epithelial function and mucosal integrity.,Khavinson bioregulators are based on the theory that short peptides can interact with DNA and regulate gene expression in a tissue-specific manner. Bronchogen is part of a broader family of bioregulators studied primarily in Russian research institutions. Published studies have appeared in Russian medical journals, though large-scale Western clinical trials are lacking.,Bronchogen remains a research compound without regulatory approval from the FDA or EMA. Most available evidence comes from small Russian clinical studies and preclinical work. It is used in complementary protocols by practitioners familiar with the Khavinson bioregulator system.
SubQ injection, any time of day. 10-20 day courses, 2-3 cycles per year with 4-6 months between courses (Khavinson protocol). Pin alone or with other bioregulators only.
Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.
How it works
Proposed to interact with DNA regulatory sequences in bronchial epithelial cells, modulating gene expression related to tissue repair and mucosal defense.,May upregulate synthesis of surfactant proteins and mucins that maintain airway surface integrity and immune barrier function.,Theorized to normalize peptide regulation in aged or damaged lung tissue, restoring protein synthesis patterns characteristic of younger, healthier tissue.
Proposed to interact with DNA regulatory sequences in bronchial epithelial cells, modulating gene expression related to tissue repair and mucosal defense.,May upregulate synthesis of surfactant proteins and mucins that maintain airway surface integrity and immune barrier function.,Theorized to normalize peptide regulation in aged or damaged lung tissue, restoring protein synthesis patterns characteristic of younger, healthier tissue.
What to expect
Days 1-7: Minimal perceptible effects. Cellular-level changes in bronchial tissue may be occurring but are not typically felt.
Evidence
Interactions & stacking
What's safe to combine, and what belongs in a separate pin.
Keep separate
Pharmacokinetics
Storage. Store refrigerated at 2-8C.
Regulatory status
Unregulated research peptide. Not approved by FDA, EMA, or other major regulatory bodies. Used primarily within the Khavinson bioregulator framework in Russia and by integrative medicine practitioners.
Put it to work
Calculate, log & track
Open Bronchogen straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.
Open Bronchogen in the app →Go deeper
The guide & community
The complete Bronchogen walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.
Join the community ↗